Radical hysterectomy + pelvic lymphadenectomy for cervical cancer
Conditions
Interventions
Sponsors
The First Affiliated Hospital of Chongqing Medical University
Eligibility
Sex/Gender
Female
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: (1) Patients diagnosed with cervical cancer, and the clinical stage (FIGO stage) is stage IA to IIA (inclusive); (2) Patients who were determined by the investigator to need radical hysterectomy (radical hysterectomy + pelvic lymphadenectomy) for cervical cancer; (3) Aged 18-75 (inclusive); (4) Be able to cooperate and complete follow-up and related examinations; (5) Voluntarily participate in this trial and sign the informed consent form.
Exclusion criteria
Exclusion criteria: (1) Preoperative imaging revealed positive pelvic or para-aortic lymph nodes; (2) Those who have received preoperative radiotherapy and/ or immunotherapy and/ or targeted therapy; (3) Those who cannot tolerate anesthesia and surgery; (4) Persons with reproductive needs; (5) Pregnant or lactating women; (6) Participating in other clinical trials of investigational drugs or devices that have not been completed; (7) Patients who are considered by the investigator to be unsuitable for participation in this program.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Rate of unconverted surgery;The incidence of device related or potentially related complications; | — |
Secondary
| Measure | Time frame |
|---|---|
| Operation time;Intraoperative bleeding;Intraoperative transfusion rate;Postoperative pain score;Postoperative 24-hour drainage volume;Number of lymph node resections;Equipment defect incidence rate;Postoperative hospitalization time;Overall incidence of surgical complications;Incidence rate of adverse events and serious adverse events; | — |
Countries
China
Contacts
Public ContactTang Junying
The First Affiliated Hospital of Chongqing Medical University
Outcome results
None listed